Susquehanna International Securities, Ltd. Grifols Sa Transaction History

Susquehanna International Securities, Ltd.

$389 Million
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$6.65 - $10.69 $67,032 - $107,755	10,080 New	10,080 $74,000
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $128,587 - $157,852	-12,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $126,604 - $189,348	12,400 New	12,400 $139,000
Q2 2021 Aug 11, 2021	SELL	$16.62 - $18.94 $2.48 Million - $2.83 Million	-149,358 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.15 - $19.78 $590,774 - $771,321	38,995 Added 35.33%	149,358 $2.58 Million
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $84,300 - $98,350	5,000 Added 4.75%	110,363 $2.04 Million
Q3 2020 Nov 16, 2020	BUY	$15.4 - $20.16 $400,400 - $524,160	26,000 Added 32.76%	105,363 $1.83 Million
Q2 2020 Aug 14, 2020	BUY	$18.24 - $21.45 $911,999 - $1.07 Million	50,000 Added 170.28%	79,363 $1.45 Million
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $17,696 - $27,859	-1,087 Reduced 3.57%	29,363 $591,000
Q4 2019 Feb 14, 2020	BUY	$19.57 - $23.52 $595,906 - $716,184	30,450 New	30,450 $709,000

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

Capital World Investors Los Angeles, CA

21M
Shares

$165 Million
0.03% of portfolio
Brandes Investment Partners, LP La Jolla, CA

19.9M
Shares

$156 Million
2.11% of portfolio
Permian Investment Partners, LP New York, NY

12.3M
Shares

$96.8 Million
16.06% of portfolio
Black Creek Investment Management Inc. Toronto, A6

11.1M
Shares

$87.2 Million
3.5% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

10.7M
Shares

$84.2 Million
0.05% of portfolio

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.

Account